0001794783false06/3000017947832026-11-102026-11-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________
FORM 8-K
_______________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2026
_____________________________________
SELECTQUOTE, INC.
(Exact name of registrant as specified in its charter)
_____________________________________
| | | | | | | | |
| Delaware | 001-39295 | 94-3339273 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
|
| 6800 West 115th Street, Suite 2511 |
Overland Park, Kansas 66211 |
(Address of principal executive offices) (Zip code) |
| | |
(913) 599-9225 |
(Registrant’s telephone number, including area code) |
|
No change since last report |
(Former Name or Address, If Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol | | Name of each exchange on which registered |
| Common Stock, $0.01 par value | | SLQT | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.03 Material Modification to Rights of Security Holders.
The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On November 10, 2026, the stockholders of SelectQuote, Inc. (the “Company”) approved and adopted an amendment to the Company’s Sixth Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to effect (a) a reverse stock split of the outstanding shares of the Company’s common stock at a reverse stock split ratio in the range of 1-for-10 to 1-for-20, as determined by the Company’s Board of Directors at a later date, and (b) a reduction in the number of authorized shares of common stock by a corresponding ratio. On November 13, 2026, the Company filed a Certificate of Amendment (the “Amendment”) to the Certificate of Incorporation with the Delaware Secretary of State to effect a one-for-twenty (1-for-20) reverse stock split (the “Reverse Stock Split”) of the Company’s outstanding common stock and a proportional reduction in the number of authorized shares of common stock. The Amendment will become effective at 11:59 p.m. Eastern Time on November 16, 2026 (the “Effective Time”).
At the Effective Time, every twenty (20) shares of the Company’s common stock issued and outstanding immediately prior to the Effective Time shall automatically be combined into one share of common stock. The total number of authorized shares of common stock will be reduced proportionately. In addition, the number of shares available for issuance under the Company’s equity compensation plans, as well as the number of shares subject to any outstanding award under the Company’s equity compensation plans, and the exercise price, grant price or purchase price relating to any such awards, will be proportionately adjusted. Proportionate adjustments will also be made to the number of shares subject to any outstanding warrants to purchase the Company’s common stock, as well as the exercise price relating to such warrants.
No fractional shares of common stock will be issued as a result of the Reverse Stock Split. Instead, any stockholder who would have been entitled to receive a fractional share as a result of the Reverse Stock Split will receive cash payments in lieu of such fractional shares. Each common stockholder will hold the same percentage of the outstanding common stock immediately following the Reverse Stock Split as that stockholder did immediately prior to the Reverse Stock Split, except to the extent that the Reverse Stock Split results in stockholders receiving cash in lieu of fractional shares.
The Company’s common stock is expected to begin trading on a split-adjusted basis on the New York Stock Exchange (the “NYSE”) at market open on November 17, 2026. The common stock will trade under a new CUSIP number, 816307409. The Reverse Stock Split is intended to increase the per-share trading price of the Company’s common stock to regain compliance with the NYSE’s continued listing standards.
The foregoing description is qualified in its entirety by the Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference. For more information regarding the Reverse Stock Split, see the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on September 30, 2026.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 10, 2026, the Company held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Of the 179,261,801 shares of the Company’s common stock outstanding as of the record date, September 18, 2026, 106,627,398 shares were represented in person or by proxy at the Annual Meeting. The results of the voting on the proposals considered at the Annual Meeting are provided below.
Proposal 1
The voting results on the proposal to elect three Class I directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier retirement or removal, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Votes For | | Votes Withheld | | Abstentions | | Broker Non-Votes |
| Timothy R. Danker | | 77,380,067 | | 4,171,463 | | — | | 25,075,868 |
| Kavita K. Patel | | 67,653,352 | | 13,898,178 | | — | | 25,075,868 |
| Christopher Wolfe | | 77,414,962 | | 4,136,568 | | — | | 25,075,868 |
Proposal 2
The voting results on the proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027 were as follows:
| | | | | | | | | | | | | | | | | | | | |
| Votes For | | Votes Against | | Abstentions | | Broker Non-Votes |
| 105,300,075 | | 840,776 | | 486,547 | | — |
Proposal 3
The voting results on the non-binding advisory proposal to approve the compensation of the Company’s named executive officers as disclosed in the Company’s 2026 proxy statement were as follows:
| | | | | | | | | | | | | | | | | | | | |
| Votes For | | Votes Against | | Abstentions | | Broker Non-Votes |
| 75,797,270 | | 4,318,474 | | 1,435,786 | | 25,075,868 |
Proposal 4
The voting results for the proposal to adopt and approve an amendment to the Certificate of Incorporation to effect (a) a reverse stock split of the outstanding shares of the Company’s common stock at a reverse stock split ratio in the range of 1-for-10 to 1-for-20, as determined by the Board of Directors at a later date, and (b) a reduction in the number of authorized shares of the Company’s common stock by a corresponding ratio, were as follows:
| | | | | | | | | | | | | | | | | | | | |
| Votes For | | Votes Against | | Abstentions | | Broker Non-Votes |
| 102,344,986 | | 4,025,515 | | 256,897 | | — |
Proposal 5
The voting results for the the proposal to approve, if necessary, the adjournment of the Annual Meeting to solicit additional proxies in favor of Proposal 4 above, were as follows:
| | | | | | | | | | | | | | | | | | | | |
| Votes For | | Votes Against | | Abstentions | | Broker Non-Votes |
| 102,549,747 | | 3,953,021 | | 124,630 | | — |
Item 7.01 Regulation FD Disclosure.
On November 13, 2026, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Forward Looking Statements
This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance. In particular, statements made herein regarding the trading of the Company’s common stock on a split-adjusted basis and the impact of the Reverse Stock Split, including any adjustments from the treatment of fractional shares, and other statements that are not historical fact, are forward-looking statements. The events and circumstances reflected in the Company’s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. These risks and uncertainties include but are not limited to the risks and uncertainties indicated in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2026 filed with the SEC on August 25, 2026, including those set forth under “Item 1A. Risk Factors,” as well as in our other filings with the SEC. Such forward-looking statements are based on information available as of the date of this Current Report on Form 8-K and the Company’s current beliefs and expectations concerning future developments and their effects on the Company and speak only as of the date of this Current Report on Form 8-K. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| | | | | |
| Exhibit No. | Description of Exhibit |
3.1 | Amendment to Sixth Amended and Restated Certificate of Incorporation |
99.1 | Press Release |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | |
| SELECTQUOTE, INC. | |
| | | |
Date: November 16, 2026 | By: | /s/ Daniel A. Boulware | |
| Name: | Daniel A. Boulware | |
| Title: | General Counsel and Secretary | |
SelectQuote, Inc. Announces 1-for-20 Reverse Stock Split
OVERLAND PARK, Kan.--(BUSINESS WIRE)-- SelectQuote, Inc. (NYSE: SLQT) — SelectQuote, Inc. (NYSE: SLQT) (“SelectQuote” or the “Company”) today announced that its board of directors (the “Board”) has approved a 1-for-20 reverse stock split of the Company’s common stock and a proportionate reduction in the number of authorized shares of common stock. At the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) on November 10, 2026, the Company’s stockholders approved an amendment to the Company’s Sixth Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-10 and 1-for-20, with the exact ratio to be determined by the Board.
The reverse stock split is intended to help the Company regain compliance with the minimum stock price requirement for continued listing on the New York Stock Exchange.
“This is an important step that aligns with our commitment to remain listed on the NYSE. While we do not believe our current equity valuation reflects the strength of our business, SelectQuote remains an industry leader with a compelling opportunity ahead. Our differentiated insurance distribution and healthcare services businesses, improving cash flow profile, and strong balance sheet provide a solid foundation for continued growth. We expect to generate more than $60 million in operating cash flow this year and have a commissions receivable balance in excess of $1 billion. Together, these strengths position SelectQuote to continue innovating, leading our markets, and delivering world-class service to the millions of customers we serve.” said Tim Danker, SelectQuote’s CEO.
The reverse stock split is expected to become effective at 11:59 p.m. Eastern Time on November 16, 2026. Shares of the Company’s common stock are expected to begin trading on a split-adjusted basis on the New York Stock Exchange at market open on November 17, 2026 under the existing trading symbol “SLQT” and a new CUSIP number of 816307 409.
Information for SelectQuote Stockholders
In connection with the reverse stock split, every 20 shares of the Company’s common stock issued and outstanding immediately prior to the effective time will be automatically reclassified and combined into 1 share of common stock. The 1-for-20 reverse stock split will reduce the number of outstanding shares of the Company’s common stock from 180,185,985 to approximately 9,009,299. Proportional adjustments will be made to the number of shares of the Company’s common stock subject to outstanding equity awards and warrants, as well as the applicable exercise price. The total number of authorized shares of the Company’s common stock will be reduced from 700,000,000 to 35,000,000.
Computershare Trust Company, N.A., the transfer agent for the Company’s common stock, will act as the exchange agent, and may be contacted at (800) 736-3001.
No fractional shares of common stock will be issued as a result of the reverse stock split. Any stockholders of common stock who would have been entitled to receive fractional shares as a result of the reverse stock split will instead receive cash payments in lieu of such fractional shares.
For more information on the reverse stock split, please refer to the proxy materials in connection with the Annual Meeting, which materials can be accessed through the investor relations portion of the Company’s website at ir.selectquote.com and on the United States Securities and Exchange Commission’s (“SEC”) EDGAR website, sec.gov.
Forward Looking Statements
This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; our use of artificial intelligence and other emerging technologies; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; our ability to regain and maintain compliance with NYSE listing standards; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers’ approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, changes in reimbursement rates under our contracts with pharmacy benefit managers, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future
results and performance, see the section entitled “Risk Factors” in the most recent Annual Report on Form 10-K and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.
About SelectQuote:
Founded in 1985, SelectQuote (NYSE: SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.
With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select which proactively connects consumers with a wide breadth of healthcare services supporting their needs.
Investor Relations:
Sloan Bohlen
877-678-4083
investorrelations@selectquote.com
Media:
Matt Gunter
913-286-4931
matt.gunter@selectquote.com
Source: SelectQuote, Inc.